Amgen Inc

Stock Chart, Company Information, and Scan Results

$331.62(as of May 8, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Amgen Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$331.62
Ticker SymbolAMGN
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - General
Employees31,500
CountyUSA
Market Cap$177,708.6M
EBIDTA16,918.0M
10-Day Moving Average333.92
P/E Ratio23.13
20-Day Moving Average341.35
Forward P/E Ratio14.81
50-Day Moving Average352.60
Earnings per Share14.38
200-Day Moving Average322.93
Profit Margin21.11%
RSI40.84
Shares Outstanding540.0M
ATR7.79
52-Week High391.29
Volume1,758,819
52-Week Low253.48
Most Recent Support Level327.22
Book Value9,190.0M
Most Recent Resistance Level332.98
P/B Ratio19.63
Upper Keltner358.88
P/S Ratio4.85
Lower Keltner323.82
Debt-to-Equity Ratio358.88
Next Earnings DateUnknown
Cash Surplus-12,917.0M
Next Ex-Dividend Date05/15/2026

Amgen is a leader in medicinal breakthroughs as it pioneered ways to use living cells to develop biological medicines. The biotech develops and commercializes drugs to treat conditions like cancer, cardiovascular disease, and bone health. The company’s top-selling drugs, Aranesp and Kyprolis, are used to treat anemia and cancer respectively.

Amgen Inc In Our Stock Scanner

As of May 08, 2026
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.